These results confirmed that ELF5 inhibited HUVEC migration and angiogenesis, suggesting that ELF5 acted as an angiogenesis suppressor in RCC and ETS domain of ELF5 is responsible of its angiogenesis suppressor activities upon ectopic expression RCC cell lines. The gene discussed is ELF5; the disease is renal cell carcinoma.